A new report from Health Management Associates highlights both the economic burden and persistent treatment gaps for individuals with treatment-resistant depression. While an estimated 34 million people in the United States experience depression, nearly one in three do not respond to first-line therapies, leaving them with ongoing symptoms and limited access to effective options.
Treatment-resistant depression carries substantial healthcare costs. Among Medicare beneficiaries, those with treatment-resistant depression incur approximately $8,000 more in annual healthcare costs than those whose depression is well managed, driven by repeated healthcare utilization and prolonged illness. Mark Desmarais, principal and lead co-author of the report, noted that “any developments in depression care which would improve outcomes for patients may lead to measurable reductions in cost burden for both Medicare and for patients.”
The toll extends beyond the individual patient to families and caregivers. Caregivers supporting individuals with treatment-resistant depression provide an average of 23-24 hours of care per week, often while managing full-time employment and household responsibilities. The analysis estimates approximately $11,000 per year in indirect costs to caregivers, with nearly $30,000 annually in direct household caregiving expenses. Adding to this burden, at least 20% of family caregivers experience depression themselves, compounding mental health challenges within families.
Access remains a critical barrier despite treatment advances. William Sauvé, MD, Chief Medical Officer at Osmind, emphasized that “ensuring access to the range of FDA-approved therapies across private insurance, Medicare, and Medicaid is essential to improving outcomes and reducing long-term costs.” The report underscores that existing treatment options remain inaccessible to many who need them most. Mental Health Awareness Month, the report concludes, should focus not only on raising awareness but on examining how well healthcare systems function for patients whose needs are more complex and difficult to treat.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.prnewswire.com/news-releases/during-mental-health-awareness-month-new-report-highlights-the-high-cost-of-treatmentresistant-depression-and-gaps-in-access-to-care-302783401.html